Otsuka sales and marketing update

Otsuka launched Abilify aripiprazole to treat schizophrenia in Japan. The product is already marketed in the U.S. and Europe by partner Bristol-Myers Squibb Co. (BMY, Princeton, N.J.). Abilify is an ...